Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Zyrexindo Mandiri Buana Tbk. (ZYRX)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Zyrexindo Mandiri Buana Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Zyrexindo Mandiri Buana Tbk. diperdagangkan di Rp127 (kapitalisasi pasar 172 M, volume 24 jam 315,2 rb). Perbedaan utamanya: Zyrexindo Mandiri Buana Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | ZYRX | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 172 M |
Volume | — | 315,2 rb |
Lot | — | 3,15 rb |
Perputaran | — | 40,04 jt |
Harga Rata-rata | — | 127,02 |
Nilai Transaksi | — | 40,04 jt |
Harga Ekuilibrium Indikatif | — | 127 |
Volume Ekuilibrium Indikatif | — | 400 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Zyrexindo Mandiri Buana Tbk.
PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Selengkapnya di halaman ZYRX →
